Rivaroxaban for venous thromboembolism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Jun 2023: Trial registered, NCT05920343
  2. 4 Nov 2024: Trial started, NCT05920343

The trials

NCT05920343: VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

State
Under way
Phase
Phase 2 and Phase 3
People
120 planned
Started
4 Nov 2024
Primary completion
Jun 2028
Arms
Rivaroxaban
Results
None posted
  1. 27 Jun 2023: Trial registered
  2. 4 Nov 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Rivaroxaban 15Mg Tab, Xarelto.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.